Privacy Policy - Sanovra Lab
1. Preamble and Interpretative Scope
In accordance with the multifaceted obligations emerging from the dynamic interplay of statutory requirements, contractual understandings, and ethical commitments, Sanovra Lab, henceforth referred to as "the Entity", articulates herein a delineation of procedural methodologies, interpretive frameworks, and precautionary undertakings regarding the acquisition, utilisation, dissemination, and retention of personal and medical data attributable to individuals engaging with our service infrastructure. This document, by virtue of its breadth, shall be construed as inclusive of all potential contingencies, irrespective of explicit anticipation at the point of compilation.
2. Acquisition of Identifiable and Non-Identifiable Data
The Entity may, through direct, indirect, automated, and semi-automated mechanisms, obtain data comprising—though not exhaustively—full legal nomenclature, geographical coordinates of domicile, telecommunications identifiers, and medical or diagnostic particulars. Such acquisition may occur via digital forms, telephonic interactions, or physical documentation, each subject to procedural variances aligned with operational exigencies and compliance imperatives.
3. Functional Deployment of Information
The deployment of collected data shall be executed in a manner congruent with the operational necessity for which said data was procured, encompassing but not restricted to: appointment scheduling, logistical coordination, diagnostic facilitation, and the ultimate transference of analytical outputs (i.e., test reports) to the data subject. Transmission to external entities shall be circumscribed exclusively to laboratories holding a verified partnership status, absent any arbitrary third-party exposure.
4. Delegated Analytical Operations
Given that Sanovra Lab abstains from executing in-house diagnostic assays, the substantive analytical undertakings are delegated to pre-vetted partner laboratories. While operational control over such laboratories remains non-absolute, the Entity affirms a policy of ancillary support wherein discrepancies, interpretative ambiguities, or anomalies arising from issued reports shall be addressed through consultative engagement with said partner entities.
5. Restriction of Report Utilisation
Any documentation, analysis, or conclusion furnished by the Entity, whether in hardcopy or electronic format, is designated for the circumscribed purpose of medical advisement and pharmacological intervention. Utilisation for forensic, evidentiary, judicial, or quasi-judicial purposes shall be deemed outside the intended operational perimeter and is expressly disclaimed as a valid application by the Entity.
6. Safeguarding Mechanisms and Preventive Protocols
The Entity implements a stratified matrix of physical, procedural, and cryptographic safeguards to mitigate the risk of unauthorised access, unauthorised alteration, and unauthorised dissemination. The efficacy of these measures is contingent upon both technological capacity extant at the time of implementation and the cooperative compliance of the data subject in adhering to prescribed security advisories.
7. Amendments and Revisions
Owing to the fluidity of operational contexts, statutory revisions, and technological evolutions, the provisions articulated herein are subject to unilateral modification by the Entity, with such modifications acquiring enforceable validity upon public posting to this document's designated digital location, absent any express requirement for individualised notification.
8. Inquiry and Correspondence Channels
All inquiries, clarifications, or contestations relating to the interpretive or practical dimensions of this Privacy Policy shall be directed to the designated compliance liaison via the following coordinates:
Email: opentmp67@gmail.com
Phone: +91-7203826884